AVTX

Avalo Therapeutics Inc

Jun 22 • 04:00PM ET

17.08

+2.38 16.19 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR NUVL RYTM INCY BMRN VKTX KRYS AXSM MDGL NBIX

| Held by: XBI VTI VXF IWC ITOT LABU TMSL BBC DFAS TMED

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.82	Insider Own	8.98%	Shs Outstand	52.57M	Perf Week	15.72%
Market Cap	897.82M	Forward P/E	-	EPS next Y	-3.03	Insider Trans	-6.33%	Shs Float	47.84M	Perf Month	4.85%
Enterprise Value	818.01M	PEG	-	EPS next Q	-0.62	Inst Own	76.36%	Short Float	13.34%	Perf Quarter	27.27%
Income	-84.74M	P/S	14963.67	EPS this Y	47.12%	Inst Trans	21.91%	Short Ratio	3.67	Perf Half Y	-11.27%
Sales	0.06M	P/B	6.16	EPS next Y	1.73%	ROA	-71.09%	Short Interest	6.38M	Perf YTD	-5.95%
Book/sh	2.77	P/C	10.93	EPS next 5Y	21.15%	ROE	-88.76%	52W High	24.27 -29.63%	Perf Year	268.10%
Cash/sh	1.56	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-120.51%	52W Low	4.50 279.56%	Perf 3Y	-98.34%
Dividend Est.	0.01 (0.07%)	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-283.05%	Volatility	9.19% 7.26%	Perf 5Y	-99.83%
Dividend TTM	-	EV/Sales	13633.50	EPS Y/Y TTM	-1121.44%	Oper. Margin	-134164.41%	ATR (14)	1.25	Perf 10Y	-99.75%
Dividend Ex-Date	-	Quick Ratio	7.66	Sales Y/Y TTM	-86.62%	Profit Margin	-143627.12%	RSI (14)	60.52	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.66	EPS Q/Q	21.93%	SMA20	16.32%	Beta	0.80	Target Price	45.25
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	10.21%	Rel Volume	1.48	Prev Close	14.70
Employees	33	LT Debt/Eq	0.03	Earnings	May 13 BMO	SMA200	9.52%	Avg Volume	1.74M	Price	17.08
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.42% -	Trades		Volume	2,539,815	Change	16.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)